| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $10.3M | -41.8% |
| SG&A Expense | $19.0M | -44.3% |
| Operating Income | -$29.3M | +40.9% |
| Interest Expense | $83K | -94.1% |
| Income Tax | $0 | — |
| Net Income | -$65.0M | -29.2% |
| EPS (Basic) | -$5.31 | +8.1% |
| EPS (Diluted) | -$5.31 |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | -81.0% |
| Accounts Receivable | $1.0M | +0.0% |
| Inventory | $3.9M | +0.0% |
| Current Assets | $26.3M | -41.7% |
| Total Assets | $41.2M | -58.5% |
| Current Liabilities | $21.6M | -29.1% |
| Total Liabilities | $25.8M | -28.1% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.4M | +18.8% |
| Capital Expenditures | $5.7M | -21.7% |
| Investing Cash Flow | $7.0M | +236.7% |
| Financing Cash Flow | $2.3M | +137.6% |
| Free Cash Flow | -$36.2M | +19.3% |
| +8.1% |
| Stockholders' Equity |
| $15.4M |
| -75.8% |